Overview
Malignant neoplasm of unknown origin (MUO) refers to cancers where the primary site of origin cannot be determined despite thorough diagnostic evaluation. Accurate diagnosis is crucial for guiding appropriate treatment strategies 1.Diagnosis
Utilize comprehensive imaging techniques including CT, MRI, and PET scans to identify potential primary sites 1.
Perform thorough histopathological examination of biopsy samples to identify tumor markers and genetic profiles 1.
Consider advanced spectroscopic methods like dynamic RBC-to-membrane ratio analysis for physiological insights, though primarily experimental and not yet standard 1.Management
Initiate treatment based on tumor histology, grade, and molecular characteristics once secondary sites are identified 1.
Chemotherapy regimens should be tailored to specific cancer types identified post-diagnosis (specific drug classes/doses not detailed in provided abstracts) 1.
Supportive care measures including pain management, symptom control, and palliative care are essential throughout management 1.Special Populations
No specific evidence provided regarding management adaptations for pregnancy, pediatrics, elderly, or comorbid conditions in the given abstracts 1.Key Recommendations
Employ a multidisciplinary approach involving imaging, histopathology, and molecular diagnostics to identify the primary site of MUO (Evidence: Moderate) 1.
Tailor therapeutic interventions based on the specific characteristics of the identified cancer type post-diagnosis (Evidence: Moderate) 1.
Integrate supportive and palliative care early in the management plan to address symptom burden and quality of life (Evidence: Expert opinion) 1.References
1 García Delgado GM, Shammi UA, Thornburgh C, Ruppel M, Parks I, Miller A et al.. Dynamic RBC-To-Membrane Ratio in . Magnetic resonance in medicine 2026. link